Around 20,000 children and young people with type 1 diabetes in England now benefit from life-changing 'artificial pancreas' technology, recommended by NICE.
SAGE reveal that in the most pessimistic scenario, a further 115,800 COVID deaths would happen by June, 2022 - but in the most optimistic 'unlockdown' output, the figure is 9,400 deaths.
The FDA have labelled the Johnson & Johnson COVID vaccine as a possible cause of Guillain-Barré syndrome - an extremely rare side effect that can potentially cause nerve damage.
Davide Villa, business development director for EMEAI at Western Digital, discusses the data storage challenges in the healthcare industry and how they can be addressed.
An Australian team found that antibodies created by infection with the virus are not effective against COVID variants - suggesting that vaccination gives stronger protection.
The British Medical Association (BMA) today (7 July) responded to UK 'unlockdown' plans - labelling the suspension of all protective measures as "incoherent", with the NHS under "immense pressure".
With the current focus on public health worldwide, Arthur Goudena, Marketing Manager of PHC Europe, explains how one of Europe’s leading biobanks plays a growing role in supporting medical research.
SAGE say the UK Governments' plans to lift all social distancing measures on 19 July are too much - they believe a rise in infections will increase ethnic minority COVID deaths.
The team will have results to discuss in April, 2022 - they nurse the hope that this HIV vaccine could stop different geographical strains, after 40 years of no cure.
While mRNA is now well-connected to Pfizer or Moderna, saRNA is a more obscure, early-stage vaccine technology - now, scientists in the UK have data suggesting that saRNA COVID vaccines could work well for most people.
A study released yesterday (28 June) found that it would be safe to mix Pfizer and AstraZeneca doses, which could speed up UK vaccine roll-out if adopted.
Indiana University School of Medicine researchers are attempting to use magnetic nanoparticles to develop a cure for neurological disorders from epilepsy to Alzheimer's - without any invasive or genetic treatment.
The UK Government will begin rollout of a third COVID dose for over-50s and vulnerable individuals, with the NHS given the go-ahead to create their pre-winter vaccination plan.
A team from Missouri University of Science and Technology, focus on water citizen science, including comment on monitoring water quality with affordable, open-source sensors & generating shared knowledge in social media.
As your specialist in Acute Care, Draeger Medical UK Ltd is focused on providing protective therapy solutions in the operating room, intensive care unit and neonatal intensive care unit. The aim has always been to improve clinical outcomes and reduce risks in acute care; which has never been truer than in the time of a global pandemic.
